Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Two microRNAs, miR-221 and miR-222, upregulated by the MET proto-oncogene, have been already described to enhance cell survival and to induce TNF-related apoptosis-inducing ligand (TRAIL) resistance in NSCLC cell lines, through the downregulation of p27(kip1), PTEN and TIMP3.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[Two microRNAs, miR-221 and miR-222, upregulated by the MET proto-oncogene, have been already described to enhance cell survival and to induce TNF-related apoptosis-inducing ligand (TRAIL) resistance in NSCLC cell lines, through the downregulation of p27(kip1), PTEN and TIMP3.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP845342.RAU2shPQXDELi6O7ZFUn2Hr_1FuwczckzV_I0-1v4guUo130_assertion description "[Two microRNAs, miR-221 and miR-222, upregulated by the MET proto-oncogene, have been already described to enhance cell survival and to induce TNF-related apoptosis-inducing ligand (TRAIL) resistance in NSCLC cell lines, through the downregulation of p27(kip1), PTEN and TIMP3.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP845342.RAU2shPQXDELi6O7ZFUn2Hr_1FuwczckzV_I0-1v4guUo130_provenance.
• assertion description "[Two microRNAs, miR-221 and miR-222, upregulated by the MET proto-oncogene, have been already described to enhance cell survival and to induce TNF-related apoptosis-inducing ligand (TRAIL) resistance in NSCLC cell lines, through the downregulation of p27(kip1), PTEN and TIMP3.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Two microRNAs, miR-221 and miR-222, upregulated by the MET proto-oncogene, have been already described to enhance cell survival and to induce TNF-related apoptosis-inducing ligand (TRAIL) resistance in NSCLC cell lines, through the downregulation of p27(kip1), PTEN and TIMP3.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Two microRNAs, miR-221 and miR-222, upregulated by the MET proto-oncogene, have been already described to enhance cell survival and to induce TNF-related apoptosis-inducing ligand (TRAIL) resistance in NSCLC cell lines, through the downregulation of p27(kip1), PTEN and TIMP3.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP905080.RATNO366-wb51ZewacxQGzzjXfIOdfrlFZZnwY8LnfrvE130_assertion description "[Two microRNAs, miR-221 and miR-222, upregulated by the MET proto-oncogene, have been already described to enhance cell survival and to induce TNF-related apoptosis-inducing ligand (TRAIL) resistance in NSCLC cell lines, through the downregulation of p27(kip1), PTEN and TIMP3.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP905080.RATNO366-wb51ZewacxQGzzjXfIOdfrlFZZnwY8LnfrvE130_provenance.
• assertion description "[Two microRNAs, miR-221 and miR-222, upregulated by the MET proto-oncogene, have been already described to enhance cell survival and to induce TNF-related apoptosis-inducing ligand (TRAIL) resistance in NSCLC cell lines, through the downregulation of p27(kip1), PTEN and TIMP3.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP905077.RAiT6kTMt9quLpA_dWChlYJdGeKg8urlu-QwQvT9QiKUk130_assertion description "[Two microRNAs, miR-221 and miR-222, upregulated by the MET proto-oncogene, have been already described to enhance cell survival and to induce TNF-related apoptosis-inducing ligand (TRAIL) resistance in NSCLC cell lines, through the downregulation of p27(kip1), PTEN and TIMP3.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP905077.RAiT6kTMt9quLpA_dWChlYJdGeKg8urlu-QwQvT9QiKUk130_provenance.
• NP905078.RApAT-LfTrWTYnnGQ_rKilPSLxV-q7FqrWNg1hlcHGF5o130_assertion description "[Two microRNAs, miR-221 and miR-222, upregulated by the MET proto-oncogene, have been already described to enhance cell survival and to induce TNF-related apoptosis-inducing ligand (TRAIL) resistance in NSCLC cell lines, through the downregulation of p27(kip1), PTEN and TIMP3.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP905078.RApAT-LfTrWTYnnGQ_rKilPSLxV-q7FqrWNg1hlcHGF5o130_provenance.
• NP303131.RA3u-8QS_PsfA-Tg9UI37bPQpT45htP0CoIki09U3AbGM130_assertion description "[Two microRNAs, miR-221 and miR-222, upregulated by the MET proto-oncogene, have been already described to enhance cell survival and to induce TNF-related apoptosis-inducing ligand (TRAIL) resistance in NSCLC cell lines, through the downregulation of p27(kip1), PTEN and TIMP3.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP303131.RA3u-8QS_PsfA-Tg9UI37bPQpT45htP0CoIki09U3AbGM130_provenance.
• NP905081.RAIR0qRF6XusqN4n9IrAGw3g62XUN9IYga3OGFAZVwtlA130_assertion description "[Two microRNAs, miR-221 and miR-222, upregulated by the MET proto-oncogene, have been already described to enhance cell survival and to induce TNF-related apoptosis-inducing ligand (TRAIL) resistance in NSCLC cell lines, through the downregulation of p27(kip1), PTEN and TIMP3.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP905081.RAIR0qRF6XusqN4n9IrAGw3g62XUN9IYga3OGFAZVwtlA130_provenance.
• NP998932.RA_l2G0Vt4pKS76eLZ-UJzCHcbnrXJiiReSGeapXfH-TU130_assertion description "[Two microRNAs, miR-221 and miR-222, upregulated by the MET proto-oncogene, have been already described to enhance cell survival and to induce TNF-related apoptosis-inducing ligand (TRAIL) resistance in NSCLC cell lines, through the downregulation of p27(kip1), PTEN and TIMP3.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP998932.RA_l2G0Vt4pKS76eLZ-UJzCHcbnrXJiiReSGeapXfH-TU130_provenance.
• NP738702.RAydPLEIR9_738eH0xa7Y4pFREJrGXgEXZvIBpvMDl_8k130_assertion description "[Two microRNAs, miR-221 and miR-222, upregulated by the MET proto-oncogene, have been already described to enhance cell survival and to induce TNF-related apoptosis-inducing ligand (TRAIL) resistance in NSCLC cell lines, through the downregulation of p27(kip1), PTEN and TIMP3.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP738702.RAydPLEIR9_738eH0xa7Y4pFREJrGXgEXZvIBpvMDl_8k130_provenance.
• NP905074.RA3XqxdyBXaBL2FeiiNv7rp97z9b4Wrk0Kscgiu742OuE130_assertion description "[Two microRNAs, miR-221 and miR-222, upregulated by the MET proto-oncogene, have been already described to enhance cell survival and to induce TNF-related apoptosis-inducing ligand (TRAIL) resistance in NSCLC cell lines, through the downregulation of p27(kip1), PTEN and TIMP3.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP905074.RA3XqxdyBXaBL2FeiiNv7rp97z9b4Wrk0Kscgiu742OuE130_provenance.